MedPath

PROBEL; Prognostics in the Treatment Evaluation of the National System for Veterans' Care

Conditions
Posttraumatische Stressstoornis, Posttraumatic Stress Disorder
Registration Number
NL-OMON29049
Lead Sponsor
Stichting Centrum '45 partner in ARQ National Psychotrauma Center, Diemen/Oegstgeest, the Netherlands
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
260
Inclusion Criteria

Soldiers and veterans who participated in a military deployment, who meet the diagnostic DSM-5 criteria for PTSD or subthreshold PTSD. Further inclusion criteria are age between 18 and 65 years and having a treatment indication for trauma-focused psychotherapy.

Exclusion Criteria

Acute suicidality and severe psychiatric co-morbidity that would impede undergoing trauma-focused therapy.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is change in PTSD symptom severity during the first year of treatment. We will develop a prognostic model that predicts treatment outcome based on PD (such as, stigma, shame, and guilt), NP (executive functions and verbal memory), and PP (the stress- and immune system) factors collected before starting and after a year of treatment.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome measures are change during the first year of treatment in depressive symptoms severity and level of daily functioning.
© Copyright 2025. All Rights Reserved by MedPath